from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1848/ureA

LFCtreatmentdescriptionclass of inhibitor

-0.709

Amikacinug/mL Amikacintranslation

-0.004

Cap5-10ug/mL Capreomycintranslation

0.305

Rox10-50 ug/mL Roxithromycintranslation

0.109

SM2-5 ug/mL Streptomycintranslation

-1.095

Tet5-10 ug/mL Tetracyclinetranslation

-1.156

Rif0.2-5ug/mL Rifampicintranscription

-0.954

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.247

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.809

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.278

CPZ10-50 ug/mL Chlorpromazinerespiration

0.583

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.158

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.753

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.819

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.128

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.219

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.833

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.809

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.755

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.408

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.629

KCN5-20 ug/mL Potassium cyaniderespiration

-0.797

NaN30.2-2 mM Sodium aziderespiration

0.542

Nigericin50 uM Nigericinrespiration

-0.670

TRC10-150 ug/mL Triclosanrespiration

-0.760

TRZ10-25 ug/mL Thioridazinerespiration

3.956

Valinomycin0.5-10 uM Valinomycinrespiration

0.194

ZnSO42 mM ZnSO4respiration

0.187

menadione6-10 ug/mL Menadionerespiration

0.262

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.211

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.041

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.156

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.045

NRP_1Non-replicating persistence stage 1dosRassociated

0.342

Amp0.2mg/mL AmpicillincellWall

0.020

Cephalexin20-100 ug/mL CephalexincellWall

0.202

Cerulenin0.32-5 ug/mL CerulenincellWall

0.713

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.368

EMB10-20 ug/mL EthambutolcellWall

0.093

Eta12-40 ug/mL EthionamidecellWall

0.455

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.422

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.168

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.201

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.355

BZA0.12 mg/mL BenzamidearomaticAmides

0.117

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.496

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.361

H2O24 mM hydrogen peroxideDNAdamaging

-0.314

Levo10 ug/mL LevofloxacinDNAdamaging

0.138

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.469

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.634

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.607

UVUV-irradiationDNAdamaging

0.262

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.152

Antimycin12.5-50 ug/mL Antimycin A?

0.200

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.828

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.699

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.196

PA8240.2-2 ug/mL PA-824?

-0.880

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.258

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.570

Verapamil50 uM Verapamil?

-0.075

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.046

methoxatin10-20 ug/mL Methoxatin?